Tryptophan

Tryptophan

SCHEMBL3827133

CSCC[C@H](N)C(=O)O.N[C@@H](Cc1c[nH]c2ccccc12)C(=O)O.N[C@@H](Cc1ccccc1)C(=O)O

nearest known ligand 0.70

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KMT2A Q03164 4/20 0.70
▸ MEN1 O00255 3/20 0.70
▸ KDM4E B2RXH2 3/20 0.70
▸ MAPT P10636 3/20 0.70
▸ LMNA P02545 2/20 0.70
▸ TSHR P16473 2/20 0.70
▸ BLM P54132 2/20 0.70
▸ PMP22 Q01453 2/20 0.70
▸ MPO P05164 1/20 0.70
▸ HIF1A Q16665 1/20 0.70
▸ CTSC P53634 3/20 0.61
▸ APAF1 O14727 1/20 0.53
▸ POLB P06746 1/20 0.53
▸ RECQL P46063 1/20 0.53
▸ L3MBTL1 Q9Y468 1/20 0.53
▸ HSP90AA1 P07900 1/20 0.53
▸ HSP90AB1 P08238 1/20 0.53
▸ LTA4H P09960 1/20 0.53
▸ PLA2G2A P14555 1/20 0.53
▸ SMN1; SMN2 Q16637 1/20 0.51

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Dl-Tryptophan SCHEMBL8937030 1.00 KMT2A (0.70) KMT2AMEN1KDM4EMAPTLMNA
Tryptophan SCHEMBL3863016 0.97 KMT2A (0.65) KMT2AMEN1KDM4EMAPTLMNA
Tryptophan SCHEMBL2229691 0.96 KMT2A (0.76) KMT2AMEN1KDM4EMAPTLMNA
Dl-Tryptophan SCHEMBL11461241 0.96 KMT2A (0.76) KMT2AMEN1KDM4EMAPTLMNA
Dl-Tryptophan SCHEMBL2229687 0.96 KMT2A (0.76) KMT2AMEN1KDM4EMAPTLMNA
Dl-Tryptophan SCHEMBL23924440 0.96 KMT2A (0.76) KMT2AMEN1KDM4EMAPTLMNA
Dl-Tryptophan SCHEMBL27415496 0.95 KMT2A (0.63) KMT2AMEN1KDM4EMAPTLMNA
Dl-Tryptophan SCHEMBL23924534 0.91 KMT2A (0.70) KMT2AMEN1KDM4EMAPTLMNA
Dl-Tryptophan SCHEMBL27596671 0.89 KMT2A (0.67) KMT2AMEN1KDM4EMAPTLMNA
Tryptophan SCHEMBL9903583 0.89 MEN1 (0.55) KMT2AMEN1KDM4EMAPTLMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2013074966-A1 USE OF PITUITARY ADENYLATE CYCLASE ACTIVATING POLYPEPTIDE (PACAP) AND PACAP ANALOGS FOR TREATING CONTRAST -INDUSED NEPHROPATHY THE ADMINISTRATORS OF THE TULANE EDUCATIONAL FUND (US) 2013-05-23 — — WO disclosed
EP-1254238-B1 NOVEL ELONGASE GENE AND METHOD FOR PRODUCING MULTIPLE-UNSATURATED FATTY ACIDS BASF SE (DE) 2009-09-16 — — EP disclosed
WO-1996029406-A2 NUCLEAR LOCALIZATION FACTOR ASSOCIATED WITH CIRCADIAN RHYTHMS THE ROCKEFELLER UNIVERSITY (US) 1996-09-26 — — WO disclosed
US-4675196-A ION EXCHANGE RESIN PIERRAL S.P.A. (IT) 1987-06-23 — — US disclosed
Send feedback